$PLSE News

Pulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026

Here's Why Pulse Biosciences, Inc (PLSE) is a Great Momentum Stock to Buy

Pulse Biosciences CEO Bought 15,000 Company Shares. Here's What That Means for Investors.

Pulse Biosciences, Inc. (PLSE) Presents at Bank of America Global Healthcare Conference 2026 - Slideshow

Pulse Biosciences, Inc. (PLSE) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript

ATM Equity Purchases by Pulse Biosciences’ Co-Chairmen Total Approximately $13.3 Million

Pulse Biosciences Co‑Chairmen, CEO Purchase ~$13.3M In Shares Via ATM Program

Is Pulse Biosciences (PLSE) Quietly Redefining Its Core Identity Around Atrial Fibrillation?

Pulse Biosciences Q1 Earnings Call Highlights

PLSE Q1 2026 Earnings Transcript

Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference

Pulse Biosciences, Inc. (PLSE) Q1 2026 Earnings Call Transcript

Pulse Biosciences (PLSE) Upgraded to Buy: What Does It Mean for the Stock?

Turbett Surgical Appoints Kevin Danahy as President and Chief Executive Officer to Lead Growth Phase

PLSE Q4 2025 Earnings Transcript

Pulse Biosciences, Inc (PLSE) Reports Q1 Loss, Lags Revenue Estimates

Pulse Biosciences Reports Business Updates and First Quarter 2026 Financial Results

Pulse Biosciences Q1 EPS $(0.27) Beats $(0.32) Estimate, Sales $401.000K Beat $400.000K Estimate

Pulse Biosciences, Inc. (PLSE) Shareholder/Analyst Call - Slideshow

Reported Saturday, Pulse Biosciences' nPulse Cardiac Catheter System Delivers 90% Kaplan-Meier Freedom From AF At One Year In Expanded 53-Subject Follow-Up Cohort